Practitioners unable or unwilling to discuss potential complications have not done their homework
In the Phase 2 trial, the most common adverse events were gastrointestinal: nausea (up to 25.6% at higher doses), diarrhea (up to 22.0%), vomiting (up to 12.2%), and constipation (up to 11.0%)
Needle-Free Application One of the biggest benefits of Melanotan nasal spray is that it doesnt require injections
Consequently, there are no data on short-term or long-term effects in humans, the potential impact on receptor interaction, toxicity, or immune reactions
Once trial slows down that 12% number is more likely to go down than up until they're available in pill form...or they become less expensive, or the side effects are less bad